FDA Adverse Event Injury Summary report: N

GMK-SPHERE TIBIAL TRAY FIXED CEMENTED SIZE T3-I4 R

MDR report key: 18613587 · Received January 31, 2024

Report

Report Number
3005180920-2024-00017
Event Type
Injury
Date Received
January 31, 2024
Date of Event
January 5, 2024
Report Date
January 31, 2024
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030827143
PMA / PMN Number
K121416
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 08 JANUARY 2024: LOT 2210623: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 25-AUG-2022. EXPIRATION DATE: 2027-AUG-01. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. CLINICAL EVALUATION PERFORMED BY MEDICAL AFFAIRS DEPARTMENT: ONE YEAR AFTER PRIMARY CEMENTED TKA, THE PATIENT COMPLAINS ABOUT ANTERIOR KNEE PAIN. THE PATELLA HAD NOT BEEN RESURFACED. WE UNDERSTAND THAT THE MAIN CAUSE FOR FURTHER SURGERY WAS THE NEED TO TREAT THE PATELLO-FEMORAL JOINT, SO WE WOULD CONSIDER IT DISEASE PROGRESSION. HOWEVER, ONCE THE JOINT WAS OPENED, SOME DOUBTS AROSE ABOUT THE STABILITY OF THE TIBIAL COMPONENT, AND THEY DECIDED TO EXCHANGE IT TO A NEW ONE. FROM THE RADIOGRAPHS SUPPLIED, WE CANNOT DETECT A MOBILIZATION OF THE TRAY OR A DEFECT IN THE IMPLANTATION, SO WE ASSUME THAT THE EXCHANGE HAS BEEN CARRIED OUT FOR PRUDENCE, A THOROUGHLY UNDERSTANDABLE DECISION. NO REASON TO SUSPECT A FAULTY DEVICE.

Description of Event or Problem · 0

AT ABOUT 1 YEAR FROM THE PRIMARY, THE PATIENT CAME IN REPORTING ANTERIOR PAIN DUE TO LOOSENING OF THE TIBIAL TRAY. THE SURGEON REVISED THE TIBIAL TRAY AND RESURFACED THE NATURAL PATELLA. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1246744 GMK-SPHERE TIBIAL TRAY FIXED CEMENTED SIZE T3-I4 R KNEE CEMENTED TIBIAL TRAY JWH MEDACTA INTERNATIONAL SA 2210623 07630030827143

Patients

Seq Age Sex Outcome Treatment
1 56 YR Female Required Intervention